Lloyd M. Sems's Insider Trades & SAST Disclosures

Lloyd M. Sems's most recent trade in Cyclacel Pharmaceuticals Inc was a trade of 31,645 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 14, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cyclacel Pharmaceuticals Inc
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 31,645 31,645 - - Stock Option (right to buy)
Cyclacel Pharmaceuticals Inc
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 15,822 18,196 (0%) 0% 0 Common Stock
Cyclacel Pharmaceuticals Inc
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,748 4,748 - - Stock Option (right to buy)
Cyclacel Pharmaceuticals Inc
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,374 2,374 (0%) 0% 0 Common Stock
Cyclacel Pharmaceuticals Inc
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades